PAC resources that have been superseded or are obsolete.
Bazedoxifene plus conjugated oestrogens (Duavive®).pdf
Bevacizumab (Avastin®) in AMD briefing.pdf
Brimonidine tartrate gel (Mirvaso®) for the treatment of facial erythema.zip
Continuous glucose monitoring.zip
Duodopa in the management of advanced Parkinsons disease.pdf
Eltrombopag for thrombocytopenia in patients with Hepatitis C infection.pdf
gammaCore vagus nerve stimulator 1.0.pdf
Linaclotide in the management of Irritable Bowel Syndrome (IBS) with constipation (IBS-C).pdf
Methotrexate - Optimisation of treatment with methotrexate.pdf
Nalmefene for reducing alcohol consumption in people with alcohol dependence.pdf
Rifaximin (Targaxan®) for preventing HE.zip
Sacubitril:valsartan for heart failure.pdf
Tocilizumab for rheumatoid arthritis.pdf
Doxylamine and pyridoxine for nausea and vomiting in pregnancy 1.0.pdf
Use of pegfilgrastim and lenograstim in adult patients receiving cytotoxic chemotherapy.pdf
Access to NHS funding following third party funded treatment .pdf
Experimental, uncertain and unproven treatments.pdf
Ongoing access to treatment following completion of NHS funded trials.pdf
Ongoing access to treatment following completion of non commercially funded trials.pdf
Ongoing access to treatment following ending of company trials.pdf
